|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Parkman Healthcare Partners LLC
✚
|
|
|---|---|
| CRD # | 300701 |
| SEC # | 801-114849 |
| CIK # | 0001777015 |
| AUM | $1.2 B (2025-03-28) |
| Employees | 12 (67% Investors, 0% Brokers) |
| Phone | 203-516-3690 |
| Address | 700 Canal Street Stamford, CT 06902 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0001777015 |
| Sector | Form 13F Holdings | Value ($M) |
|---|---|---|
| CVS Caremark Corp | 35.7 | |
| Insulet Corp | 33.2 | |
| Boston Scientific Corp | 30.4 | |
| Alnylam Pharmaceuticals Inc | 30.1 | |
| Tenet Healthcare Corp | 29.7 | |
| Cooper Companies Inc | 27.4 | |
| Lilly Eli & Co | 26.0 | |
| Qiagen NV | 23.9 | |
| Zimmer Holdings Inc | 21.9 | |
| Danaher Corp /DE/ | 21.7 | |
| Neurocrine Biosciences Inc | 20.9 | |
| Stryker Corp | 19.9 | |
| Dexcom Inc | 19.7 | |
| Edwards Lifesciences Corp | 19.7 | |
| Verona Pharma PLC | 18.7 | |
| Signal Genetics Inc | 18.2 | |
| Quintiles Transnational Holdings Inc | 17.3 | |
| CM Life Sciences Inc | 16.2 | |
| Perkinelmer Inc | 15.2 | |
| Gilead Sciences Inc | 14.6 | |
| Kiniksa Pharmaceuticals Ltd | 13.5 | |
| McKesson Corp | 12.8 | |
| BioMarin Pharmaceutical Inc | 12.4 | |
| Desert Gateway Inc | 12.2 | |
| Schrodinger Inc | 11.8 | |
| Arcellx Inc | 11.5 | |
| Quidelortho Corp | 11.1 | |
| Outset Medical Inc | 10.5 | |
| MBX Biosciences Inc | 9.9 | |
| Xeris Biopharma Holdings Inc | 9.8 | Prev | Page 1 | Next |
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Parkman Venture Partners SPV I LP | [2023-03-27] | 9.2 | 4.1 |
| HF | Parkman HP Master Fund LP | [2019-07-02] | 118.6 | 464.9 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 1,219.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 1,219.8 |
| By Discretionary | ||
| Discretionary | 8 | 1,219.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 1,219.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 1,215.6 | |
| United States Persons | 4.2 | |
| Total | 8 | 1,219.8 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Mark Cook | 124 | ||
| Vijayabalan Murugesu | 126 | ||
| Parkman Healthcare Partners LLC | 3 | ||
| Parkman Venture Partners GP LLC | 1 | ||
| Gregory Martinez | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001777015] | |
| SC 13G | [0001777015] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Parkman Healthcare Partners LLC | Plus Therapeutics Inc | [2022-02-04] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
P2 Capital Partners LLC
✚
|
NY | 1.3 |
|
Preston Capital LLC
✚
|
CA | 1.3 |
|
Sentinel Dome Partners LLC
✚
|
CA | 1.3 |
|
New State Capital Partners LLC
✚
|
NY | 1.2 |
|
Zenyth Advisors LLC
✚
|
NY | 1.2 |
|
Tekne Capital Management LLC
✚
|
NY | 1.2 |
|
CC Management GP LLC
✚
|
NC | 1.2 |
|
Rice Park Capital Management LP
✚
|
MN | 1.2 |
|
Chilton Investment Company Inc
✚
|
CT | 1.2 |
|
Compass Group LLC
✚
|
NY | 1.2 |